{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:00:05Z","timestamp":1787583605236,"version":"build-2736575974"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Patients with rheumatoid arthritis (RA) and interstitial lung disease (ILD) have increased mortality compared to the general population and factors capable of predicting RA-ILD long-term clinical outcomes are lacking. In oncology, radiomics allows the quantification of tumour phenotype by analysing the characteristics of medical images. Using specific software, it is possible to segment organs on high-resolution computed tomography (HRCT) images and extract many features that may uncover disease characteristics that are not detected by the naked eye. We aimed to investigate whether features from whole lung radiomic analysis of HRCT may alone predict mortality in RA-ILD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>High-resolution computed tomographies of RA patients from January 2012 to March 2022 were analyzed. The time between the first available HRCT and the last follow-up visit or ILD-related death was recorded. We performed a volumetric analysis in 3D Slicer, automatically segmenting the whole lungs and trachea <jats:italic>via<\/jats:italic> the Lung CT Analyzer. A LASSO-Cox model was carried out by considering ILD-related death as the outcome variable and extracting radiomic features as exposure variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We retrieved the HRCTs of 30 RA-ILD patients. The median survival time (interquartile range) was 48 months (36\u2013120 months). Thirteen out of 30 (43.33%) patients died during the observation period. Whole line segmentation was fast and reliable. The model included either the median grey level intensity within the whole lung segmentation [high-resolution (HR) 9.35, 95% CI 1.56\u201355.86] as a positive predictor of death and the 10th percentile of the number of included voxels (HR 0.20, 95% CI 0.05\u20130.84), the voxel-based pre-processing information (HR 0.23, 95% CI 0.06\u20130.82) and the flatness (HR 0.42, 95% CI 0.18\u20130.98), negatively correlating to mortality. The correlation of grey level values to their respective voxels (HR 1.52 95% CI 0.82\u20132.83) was also retained as a confounder.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Radiomic analysis may predict RA-ILD patients\u2019 mortality and may promote HRCT as a digital biomarker regardless of the clinical characteristics of the disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1069486","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:54:59Z","timestamp":1673265299000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study"],"prefix":"10.3389","volume":"9","author":[{"given":"Vincenzo","family":"Venerito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreina","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlea","family":"Lavista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Scardapane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/acr.24120","article-title":"The roles of post-diagnosis accumulation of morbidities and lifestyle changes on excess total and cause-specific mortality risk in rheumatoid arthritis.","volume":"73","author":"Yoshida","year":"2021","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40674-020-00160-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: current update on prevalence, risk factors, and pharmacologic treatment.","volume":"6","author":"Huang","year":"2020","journal-title":"Curr Treatm Opt Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population based study.","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.21037\/jtd.2019.03.28","article-title":"Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.","volume":"11","author":"Manfredi","year":"2019","journal-title":"J Thorac Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/1744666X.2021.1905524","article-title":"Rheumatoid arthritis related interstitial lung disease.","volume":"17","author":"Manfredi","year":"2021","journal-title":"Expert Rev Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease.","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0875-x","article-title":"Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device).","volume":"19","author":"Manfredi","year":"2019","journal-title":"BMC Pulm Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype.","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12061501","article-title":"Different lung parenchyma quantification using dissimilar segmentation software: a multi-center study for COVID-19 patients.","volume":"12","author":"Risoli","year":"2022","journal-title":"Diagnostics (Basel)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/bimj.201700232","article-title":"A comparison of model selection methods for prediction in the presence of multiply imputed data.","volume":"61","author":"Thao","year":"2019","journal-title":"Biom J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/imj.14670","article-title":"Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study.","volume":"50","author":"Manfredi","year":"2020","journal-title":"Intern Med J."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105133","article-title":"Predictors of mortality in rheumatoid arthritis-associated lung disease: a retrospective study on ten years.","volume":"88","author":"Ekici","year":"2021","journal-title":"Joint Bone Spine."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13474-w","article-title":"Predictors of long-term prognosis in rheumatoid arthritis-related interstitial lung disease.","volume":"12","author":"Chen","year":"2022","journal-title":"Sci Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1093\/rheumatology\/keab828","article-title":"Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometry.","volume":"61","author":"Alevizos","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092132","article-title":"Prediction of breast cancer histological outcome by radiomics and artificial intelligence analysis in contrast-enhanced mammography.","volume":"14","author":"Petrillo","year":"2022","journal-title":"Cancers (Basel)."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/app11177833","article-title":"Radiomics analysis in ovarian cancer: a narrative review.","volume":"11","author":"Arezzo","year":"2021","journal-title":"Appl Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D slicer as an image computing platform for the quantitative imaging network.","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1093\/rheumatology\/keac184","article-title":"Automated quantification system predicts survival in rheumatoid arthritis-associated interstitial lung disease.","volume":"61","author":"Oh","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1093\/rheumatology\/keac329","article-title":"Quantitative chest imaging and prediction of mortality in rheumatoid arthritis\u2013associated interstitial lung disease.","volume":"61","author":"McDermott","year":"2022","journal-title":"Rheumatology."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1069486\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:55:06Z","timestamp":1673265306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1069486\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":20,"alternative-id":["10.3389\/fmed.2022.1069486"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1069486","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"1069486"}}